Cargando…

Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D

BACKGROUND: Fecal microbiota transplantation (FMT) has emerged as a new therapy targeting gastrointestinal microbiota for the treatment of a growing number of diseases in recent years. Previous studies have suggested that FMT may be a potential therapy for type 2 diabetes (T2D), but the underlying m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wensu, Xia, Zhaoxin, Zhu, Yi, Tang, Hao, Xu, Huaming, Hu, Xinyi, Lin, Chunhui, Jiang, Tong, He, Pei, Shen, Jilu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184852/
https://www.ncbi.nlm.nih.gov/pubmed/37197060
http://dx.doi.org/10.2147/DMSO.S404352
_version_ 1785042224002629632
author Yang, Wensu
Xia, Zhaoxin
Zhu, Yi
Tang, Hao
Xu, Huaming
Hu, Xinyi
Lin, Chunhui
Jiang, Tong
He, Pei
Shen, Jilu
author_facet Yang, Wensu
Xia, Zhaoxin
Zhu, Yi
Tang, Hao
Xu, Huaming
Hu, Xinyi
Lin, Chunhui
Jiang, Tong
He, Pei
Shen, Jilu
author_sort Yang, Wensu
collection PubMed
description BACKGROUND: Fecal microbiota transplantation (FMT) has emerged as a new therapy targeting gastrointestinal microbiota for the treatment of a growing number of diseases in recent years. Previous studies have suggested that FMT may be a potential therapy for type 2 diabetes (T2D), but the underlying mechanism remains unclear. Therefore, in the present study, we aimed to investigate the role of FMT in T2D and its underlying mechanisms. METHODS: To induce T2D, mice were fed a high-fat diet and injected with low-dose streptozotocin (STZ) for four weeks. The mice were then randomly divided into four groups: control group (n = 7), T2D group (n = 7), metformin (MET)-treated group (n = 7), and FMT group (n = 7). The MET group was orally administered 0.2 g/kg MET, the FMT group was orally administered 0.3 mL of bacterial solution, and the other two groups were orally administered the same volume of saline for four weeks. Serum and fecal samples were collected for non-targeted metabolomics, biochemical indicators, and 16S rRNA sequencing, respectively. RESULTS: Our results demonstrated that FMT had a curative effect on T2D by ameliorating hyperlipidemia and hyperglycemia. Using 16S rRNA sequencing and serum untargeted metabolomic analysis, we found that FMT could restore the disorders of gastrointestinal microbiota in T2D mice. Moreover, corticosterone, progesterone, L-urobilin, and other molecules were identified as biomarkers after FMT treatment. Our bioinformatics analysis suggested that steroid hormone biosynthesis, arginine, proline metabolism, and unsaturated fatty acid biosynthesis could be potential regulatory mechanisms of FMT. CONCLUSION: In summary, our study provides comprehensive evidence for the role of FMT in the treatment of T2D. FMT has the potential to become a promising strategy for the treatment of metabolic disorders, T2D, and diabetes-related complications.
format Online
Article
Text
id pubmed-10184852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-101848522023-05-16 Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D Yang, Wensu Xia, Zhaoxin Zhu, Yi Tang, Hao Xu, Huaming Hu, Xinyi Lin, Chunhui Jiang, Tong He, Pei Shen, Jilu Diabetes Metab Syndr Obes Original Research BACKGROUND: Fecal microbiota transplantation (FMT) has emerged as a new therapy targeting gastrointestinal microbiota for the treatment of a growing number of diseases in recent years. Previous studies have suggested that FMT may be a potential therapy for type 2 diabetes (T2D), but the underlying mechanism remains unclear. Therefore, in the present study, we aimed to investigate the role of FMT in T2D and its underlying mechanisms. METHODS: To induce T2D, mice were fed a high-fat diet and injected with low-dose streptozotocin (STZ) for four weeks. The mice were then randomly divided into four groups: control group (n = 7), T2D group (n = 7), metformin (MET)-treated group (n = 7), and FMT group (n = 7). The MET group was orally administered 0.2 g/kg MET, the FMT group was orally administered 0.3 mL of bacterial solution, and the other two groups were orally administered the same volume of saline for four weeks. Serum and fecal samples were collected for non-targeted metabolomics, biochemical indicators, and 16S rRNA sequencing, respectively. RESULTS: Our results demonstrated that FMT had a curative effect on T2D by ameliorating hyperlipidemia and hyperglycemia. Using 16S rRNA sequencing and serum untargeted metabolomic analysis, we found that FMT could restore the disorders of gastrointestinal microbiota in T2D mice. Moreover, corticosterone, progesterone, L-urobilin, and other molecules were identified as biomarkers after FMT treatment. Our bioinformatics analysis suggested that steroid hormone biosynthesis, arginine, proline metabolism, and unsaturated fatty acid biosynthesis could be potential regulatory mechanisms of FMT. CONCLUSION: In summary, our study provides comprehensive evidence for the role of FMT in the treatment of T2D. FMT has the potential to become a promising strategy for the treatment of metabolic disorders, T2D, and diabetes-related complications. Dove 2023-05-11 /pmc/articles/PMC10184852/ /pubmed/37197060 http://dx.doi.org/10.2147/DMSO.S404352 Text en © 2023 Yang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yang, Wensu
Xia, Zhaoxin
Zhu, Yi
Tang, Hao
Xu, Huaming
Hu, Xinyi
Lin, Chunhui
Jiang, Tong
He, Pei
Shen, Jilu
Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
title Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
title_full Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
title_fullStr Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
title_full_unstemmed Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
title_short Comprehensive Study of Untargeted Metabolomics and 16S rRNA Reveals the Mechanism of Fecal Microbiota Transplantation in Improving a Mouse Model of T2D
title_sort comprehensive study of untargeted metabolomics and 16s rrna reveals the mechanism of fecal microbiota transplantation in improving a mouse model of t2d
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184852/
https://www.ncbi.nlm.nih.gov/pubmed/37197060
http://dx.doi.org/10.2147/DMSO.S404352
work_keys_str_mv AT yangwensu comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT xiazhaoxin comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT zhuyi comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT tanghao comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT xuhuaming comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT huxinyi comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT linchunhui comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT jiangtong comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT hepei comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d
AT shenjilu comprehensivestudyofuntargetedmetabolomicsand16srrnarevealsthemechanismoffecalmicrobiotatransplantationinimprovingamousemodeloft2d